Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-22

Clinical Trial Update: Lianhua Qingke for the Rehabilitation of Patient With Omicron Infection [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for Lianhua Qingke in rehabilitation of patients with Omicron infection is listed, with unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lianhua Qingke

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Coronavirus, Traditional Chinese Medicine | Phase 4 | Status: UNKNOWN